Evidence map›Paper›PMID 38155289›Full record

Observational studyScientific reports2023

An observational multi-center study on type 2 diabetes treatment prescribing pattern and patient adherence to treatment.

Muhammad Daoud Butt, Siew Chin Ong, Azra Rafiq, Tooba Malik, Ahsan Sajjad, Nighat Batool, Anwaar Ul Hassan Chughtai, Muhammad Umar Wahab, Muhammad Abdullah, Zaheer-Ud-Din Babar

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 5 countries.

Muhammad Daoud ButtDiscipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia.
Siew Chin OngDiscipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia. siewchinong@usm.my.
Azra RafiqMiddle East Technical University, Ankara, Turkey.
Tooba MalikDepartment of Public Health, Health Services Academy, Islamabad, 45320, Pakistan.
Ahsan SajjadIbn Sina Community Clinic South Wilcrest Drive, Houston, TX, 77099, USA.
Nighat BatoolPak-Austria Fachhochschule: Institute of Applied Sciences and Technology, Haripur, KPK, Pakistan.
Anwaar Ul Hassan ChughtaiFaculty of Medicine and Community Health, University of Oslo, Oslo, Norway.
Muhammad Umar WahabUmar Diabetes and Foot Care Centre and Umar Diabetes Foundation, Office 1, Executive Complex, G8 Markaz, Islamabad, 46000, Pakistan.
Muhammad AbdullahDepartment of Pharmacy, Punjab University College of Pharmacy, Allama Iqbal Campus, University of the Punjab, Lahore, 54000, Pakistan.
Zaheer-Ud-Din BabarDepartment of Pharmacy, University of Huddersfield, Huddersfield, UK.
Health Services Academy · PKPak-Austria Fachhochschule: Institute of Applied Sciences and Technology · PKQuaid-i-Azam University · PKRiphah International University · PKUniversiti Sains Malaysia · MYUniversity of Huddersfield · GBUniversity of Oslo · NOUniversity of the Punjab · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2021, the International Diabetes Federation (IDF) reported that the prevalence of diabetes in Pakistan was 9.6%, higher than the global average. However, adherence to treatment guidelines, e.g., American Diabetes Association and Pakistan Endocrine Society and prescription patterns for Oral anti-diabetes (OAD), is poorly understood in Pakistan. Therefore, this study aimed to examine the prescribing practices of anti-diabetic medications, an association of lifestyle modification with drugs prescribed, and their effectiveness in preserving ideal glycemic levels in diabetic patients undergoing treatment in tertiary care teaching hospitals in rural and urban Pakistan. In this cross-sectional study, data were collected from prescriptions of outpatient diabetic patients from different rural and urban tertiary care hospitals between October 2021 and February 2022. 388 participants were enrolled in the study for a detailed interview on prescription evaluation and glycemic control. The coinvestigators conducted an interview with the patient and used a pre-validated questionnaire to collect the data. The relationship between following treatment guidelines and clinical and demographic factors was found using chi-square tests for bivariate analyses. The study reported that out of 388, the mean ages of the patients were 48 ± 12.4, and the majority were female. It was observed that 60.1% and 66.5% have uncontrolled fasting and random blood glucose, respectively. The education level of the study participants was also below par to have a complete understanding of the medical condition and self-management therapy. Even though they were taking the right medications-an average prescription regimen included 5.08 medications-52.1% of the studied people had glycated haemoglobin (HbA1c) levels higher than the therapeutic threshold set by the International Diabetes Federation. In this modern era, it was observed that the prescribing trend was still focused on traditional therapeutic options Biguanides, sulfonylureas, and dipeptidyl peptidase-4 inhibitors were prescribed in 64.6% of the patients. A significant association was found between glycemic control and body mass index, adherence to lifestyle modifications, and the number of medications prescribed (p-value < 0.05). The study reveals that Pakistan's prescribing practices do not align with international and national guidelines, leading to a high prevalence of uncontrolled diabetes and widespread use of polypharmacy among patients. To address this issue, policymakers should prioritize establishing a comprehensive national diabetes action plan. Additionally, there is a pressing need to develop diabetes education and awareness programs emphasizing the importance of lifestyle modifications for effective diabetes management.

Indexed as

Diabetes Mellitus, Type 2Cross-Sectional StudiesFemaleGlycated HemoglobinHumansHypoglycemic AgentsMaleMedication AdherenceSulfonylurea CompoundsGlycated HemoglobinHypoglycemic AgentsSulfonylurea Compounds

Identifiers

PMID38155289
PMCPMC10754831
OpenAlexW4390345804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.